Stephen Dance joined Teneobio in February 2016 and brings over thirty years’ experience in finance and accounting. Prior to joining Teneobio, Mr. Dance was Chief Financial Officer at Apple Tree Partners, a life sciences venture capital firm, from 2011 to 2013. He held the same position at NICHQ Inc., a company focused on improving health outcomes for children, from 2009 to 2011. Prior to that, he served as Senior Vice President, Finance and Chief Financial Officer at ViaCell, Inc., a biotechnology company, from 2004 to 2007, including taking ViaCell public in 2005. He was Senior Vice President, Finance and Chief Financial Officer at SangStat Medical Corporation, a publicly-held biotechnology company, from 1999 to 2003 when SangStat was acquired by Genzyme (now Sanofi). Mr. Dance also spent fifteen years with Syntex Corporation, a pharmaceuticals company (now part of the Roche group), in a variety of increasingly responsible finance positions including controller of all US pharmaceutical operations. Mr. Dance started his career with Deloitte & Touche in the London and San Francisco offices. He is a CPA and holds a B.A. degree in French and Spanish from the University of Leeds in England.